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Abstract The present study characterizes the effects of the
boric acid binding on calf thymus DNA (ct-DNA) by spec-
troscopic and calorimetric methods. UV–Vis absorbance spec-
troscopy, circular dichroism (CD) spectroscopy, transmission
electron microscopy (TEM), isothermal titration calorimetry
(ITC), and Fourier transform infrared (FT-IR) spectroscopy
were employed to characterize binding properties. Changes in
the secondary structure of ct-DNA were determined by CD
spectroscopy. Sizes and morphologies of boric acid–DNA
complexes were determined by transmission electron micros-
copy (TEM). The kinetics of boric acid binding to calf thymus
DNA (ct-DNA) was investigated by isothermal titration calo-
rimetry (ITC). ITC results revealed that boric acid exhibits a
moderate affinity to ct-DNA with a binding constant (Ka) of
9.54×104 M−1. FT-IR results revealed that boric acid binds to
the deoxyribose sugar of DNA without disrupting the B-
conformation at tested concentrations.
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Introduction
Boron is a non-metallic element well-known in biochemistry
for its properties of catenation and has recently attracted
considerable attention in the development of potential thera-
peutic and delivery agents. In a manner analogous to carbon
atoms in organic compounds, boron atoms can be linked in a
series of covalent bonds to form a number of structures, such
as polyhedral boranes, that display properties of considerable
interest for biomedical applications. These properties include
a low chemical reactivity and a high resistance to enzymatic
degradation and have triggered the design of various boron-
based materials to be utilized in biological systems [1]. Other
medical applications of boron are primarily related to the
element’s capacity to absorb neutrons, and the potential of
this element for use in cancer therapy was recognized as early
as the 1950s [2]. Boric acid in particular is principally utilized
in boron neutron capture therapy (BNCT), a non-invasive
therapeutic method for the treatment of various cancers [3]
and especially brain tumors [1, 4]. To date, several strategies
have been employed to selectively deliver boron atoms or
boron derivative drugs into tumor cells [5] by the use of
various agents, such as liposomes [6, 7] and nanoparticles [8].
There are several studies conducted on the antitumor ac-
tivity of boric acid itself. Barranco showed that boric acid is
effective for preventing prostate cancer [9] and reported the
cytotoxic effects of boric acid on prostate cancer cells [10],
and the effectiveness of boric acid for the inhibition of breast
cancer cells’ growth was also noted in the literature [11, 12].
However, the therapeutic potential of boric acid and its deriv-
atives is yet to be established in full, and the effects of these
compounds on healthy and diseased tissues remain largely
unknown. As such, the precise metabolic effects of boric acid
on key organic molecules, such as nucleic acids, need to be
investigated in order to evaluate the potential of this com-
pound, as well as other boron derivatives, in biomedical
applications.
The mononuclear species boric acid B(OH)3 and borate
B(OH)4 have been reported as the main forms of inorganic
boron. The present study focuses on boric acid as the boron
compound of interest, as the hydroxyl groups of boric acid can
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readily interact with water molecules associated with biolog-
ical ligands, and boric acid is known to form covalent and
ester bonds with such molecules [13]. Calf thymus DNAwas
selected as our organic compound of choice, because it is an
attractive target of many potent chemotherapeutics which act
by interacting with DNA of tumor cells (by intercalation,
inter- or intrastrand cross-linking, or binding to the N3 atom
of DNA purines) and inorganic boron compounds can pro-
duce lethal effect if they are located within or near the cancer
cell nucleus [14]. Consequently, a greater understanding of the
basic mechanism between DNA–boric acid interactions may
allow the design of novel boron derivates for cancer
inhibition.
The present study characterizes the interactions between
boric acid (BA) and calf thymus DNA (ct-DNA) using several
spectroscopic, calorimetric, and microscopic methods.
Briefly, the binding of BA to ct-DNA was initially analyzed
using absorbance studies, changes in the secondary structure
of ct-DNA following boric acid binding were investigated by
circular dichroism (CD) spectroscopy, transmission electron
microscopy (TEM)was utilized to investigate the morphology
of BA–ct-DNA complexes, and infrared spectroscopy was
used to understand the binding mode and conformational
changes in boric acid bound DNA. Isothermal titration calo-
rimetry (ITC) was utilized to obtain vital information about
binding constant and affinities of BA–ct-DNA complex.
Materials and Methods
Materials
C a l f t h y m u s D NA , b o r i c a c i d , a n d T r i s
[tris(hydroxymethyl)aminomethane)-HCl] were purchased
from Sigma-Aldrich (USA). Tris-EDTA (TE) was purchased
from Invitrogen (USA). Both reagents were used as supplied
without further purification. Tris-EDTA (TE) [10 mM Tris, pH
8.0 (Tris–base and Tris–HCl) and 0.1 mM EDTA] or 0.01 M
Tris-HCl buffer (pH 7.5) was used as buffer medium in all
experiments. Buffer pH was adjusted using NaOH or HCl.
A stock solution of boric acid was prepared by dissolving
boric acid in double-distilled water to a final concentration of
31 mg/ml and diluted as necessary to obtain the desired
concentrations of boric acid prior to each experiment.
Calf thymus DNA stock solutions (0.1 mg/ml DNA or
1.18×10−4 M base pairs) [15] were obtained by directly
dissolving ct-DNA in buffer. Molarities of calf thymus DNA
solutions were confirmed by spectrophotometric analysis (as-
suming ε260=6,600 M
−1 cm−1 [16]). The ratio of absorbance
at 260 and 280 nm was determined to verify solution purity,
and a ratio between 1.7 and 2.0 was taken to indicate that the
DNA samples were satisfactorily free of protein [17–20].




UV absorbance measurements were carried out on a Thermo
Scientific Nanodrop 2000 benchtop spectrophotometer
(Thermo Fisher Scientific, USA). For ultraviolet–visible
(UV–Vis) spectroscopic measurements, mixtures of boric acid
and ct-DNAwere prepared by adding a constant concentration
(0.01 mM) of ct-DNA to varying concentrations of boric acid
(0.01, 0.05, 0.1, and 0.50mM) in 0.01MTris-EDTA (pH 8.0).
In order to obtain homogeneous solutions, all DNA and boric
acid mixtures were vortexed before each bout of use. Plotting
was conducted using GraphPad Prism5 software (La Jolla,
CA).
Circular Dichroism Spectroscopy
A Jasco J-815 spectrophotometer (Jasco, Japan) was used to
record the circular dichroism (CD) spectra of calf thymus
DNA and boric acid mixtures in the 200–320 nm range. A
quartz cell with a path length of 5.0 mm was utilized for all
measurements. Titration experiments were performed with a
mixture of 0.1 mM boric acid (BA) and 0.1 mM ct-DNA in
10 mMTris-HCl (pH 7.5). CDmeasurements were performed
with a scan speed of 100 nm/min at 25 °C in a nitrogen
atmosphere.
Fig. 1 UV–Vis spectra of the calf thymus DNA in 0.01M TE buffer (pH
8.0) in the presence and absence of boric acid (BA). Total volume was
constant. Arrow shows absorbance change upon increasing concentra-
tions of boric acid. a Free ct-DNA (0.01 mM) and DNA–BA complexes
with varying DNA/BA ratios—b [1:1], c [1:5], d [1:10], and e [1:50]
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Transmission Electron Microscopy
Size and morphologies of BA–ct-DNA mixtures were deter-
mined by transmission electron microscopy. Transmission
electron microscopy (TEM) samples were prepared by over-
night incubation of boric acid with ct-DNA in water at 4 °C. A
drop of this mixture was placed on a copper TEM grid coated
with carbon film and negative stained with 2 % uranyl
acetate for 5 min. Following staining, the excess solu-
tion on grid was removed by pipetting, and the grid was
allowed to air dry prior to imaging. Images were obtained
with a Tecnai G2 Spirit Biotwin microscope (FEI, USA) set to
an accelerating voltage of 80 kV.
Fourier Transform Infrared Spectroscopy
Fourier transform infrared (FT-IR) spectra of ct-DNA and BA
mixtures were obtained using a Nicolet 6700 FT-IR
Spectrometer (Thermo-Scientific, US). Varying concentra-
tions of BA were incubated with a final DNA concentration
of 1 mM. After 3 h of incubation, 20 μl of final solution was
pipetted and subsequently dried on a 96-well plate at 37 °C for
Fig. 2 (a) CD spectra of (dashed
line) free ct-DNA and BA–DNA
mixtures in 10 mM Tris-HCl (pH
7.5). (b) CD spectra changes of
ct-DNA are plotted as a function
of increased BA concentration
relative absorption at 247 nm and
(c) at 277 nm. Arrows indicate
CD spectrum change with
increasing boric acid (BA)
concentration
Fig. 3 TEM images of (a) free ct-
DNA (0.1 mM), (b) 1 mM free
BA, and (c) 0.1 mM ct-DNA+
1 mM BA mixture. All samples
were in double-distilled water
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1 h prior to FT-IR transmittance analysis. All measure-
ments were performed at room temperature. The spec-
troscopy software OMNIC was used for measurements
and basic modifications such as baseline and back-
ground corrections. Background corrections for H2O
and CO2 were carried out for each analysis. Experiments
were run in at least three separate batches, each batch
contained triplicate samples. Four-point data smoothing was




line adjustment. ITC data were acquired in two modes, the
upper panel denoting heat flow versus time and the lower
panel reflecting energy exchange per mole of sample in the
syringe [21].
Thermodynamic parameters were calculated by the follow-
ing formula:
ΔG0 ¼ −RTInKa ¼ ΔH–TΔS0 ð1Þ




UV–Vis spectroscopy of unmodified DNAyields a sigmoidal
curve that typically peaks at 260 nm. Following the confirma-
tion of this peak, absorption spectral titration experiments can
be utilized to observe changes in absorbance peaks and shifts
in the absorbed wavelengths, which reflect changes in the
DNA secondary structure [3]. Molecule– and ion–DNA asso-
ciations in particular result in the denaturation of the DNA
helical structure due to the disruption of the hydrogen bonds
between base pairs [22, 23].
Absorption spectral titration experiments were performed
and evaluated to determine that boric acidmoieties are capable
of binding to ct-DNA. Our results demonstrate that a molec-
ular association exists between boric acid and ct-DNA
(Fig. 1). Although the absorbance change at 260 nm is negli-
gible at lower concentrations of BA, it is increased signifi-
cantly at higher concentration which results from DNA dena-
turation. The observed hyperchromism without any shift is
related to the non-intercalative binding of small molecule [24,
25]. Furthermore, an ethidium bromide displacement assay
was utilized to determine the strength of non-intercalative
binding between BA and ct-DNA. Our results confirmed the
absorbance study, as the addition of boric acid to the ct-DNA-
bound ethidium bromide did not result in a significant reduc-
tion in emission intensities (data not shown). The binding
mode of boric acid to calf thymus DNA was further investi-
gated by several calorimetric and spectroscopic methods.
Circular Dichroism Spectra
Base staking of DNA nucleotides was reported to yield a
positive CD band at 277 nm, and the helicity of DNA in turn
generates a negative CD band at 247 nm [26]. As shown in
Fig. 2a, bands associated with free ct-DNA display a classical
Gaussian shape, which is characteristic of the B-DNA
Table 1 Peak positions and
spectral shifts of the free ct-DNA
and ct-DNA–BA complex at dif-
ferent molar ratios
Concentration of ct-DNAwas
kept constant (1 mM) for all
samples








Guanine 1715 0 0 0
Thymine 1663 0 −1 0
Adenine 1604 +2 +1 −2
Cytosine 1496 +1 0 +3
Phosphate asymmetric 1231 +7 +8 +6
Phosphate symmetric 1084 +1 0 0
Sugar phosphate 1055 0 −6 −2
Backbone marker 967 0 0 +2
Deoxyribose 891 −10 −10 −9
B-conformation marker 825 −3 −1 −3
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Isothermal titration calorimetry (ITC) measurements
were performed at 25 °C (±0.2) on an ITC200 microcal-
orimeter (Microcal®, USA). The data was analyzed
using a one-site binding model by the Windows-based
Origin software pack (Microcal®, USA). A ct-DNA
concentration of 0.5 mM was present in the cell, and
a 5 mM boric acid solution was used in the syringe. In
order to prevent the potential protonation of the buffer,
sample and titrant solutions were prepared in double-
distilled water. Solutions were degassed before each titra-
tion experiment, and ITC data were evaluated following base-
conformation [27]. An intensity increase at the 277-nm band,
which is indicative of a conformational change from B to A-
DNA [28], was not observed in our BA–ct-DNA samples.
However, following the addition of boric acid, the intensity of
both positive and negative peaks decreased gradually and
without experiencing significant shifts. The absence of shifts
in the CD spectrum rules out the possibility of conformational
change in DNA following the addition of boric acid.
Figure 2b, c shows changes in CD spectra following the
addition of boric acid. Zaludova et al. reported that decreases
in the positive CD band at around 280 nm were indicative of
the presence of denaturated regions [29]. Therefore, the re-
duction observed in our dichroic bands may also correspond
to the degradation of nucleotides which is consistent with our
UV–Vis spectroscopy result.
Transmission Electron Microscopy
The general morphology of BA–DNA complexes was ob-
served using TEM images. Structures of free ct-DNA and free
boric acid are shown in Fig. 3a, b.
Free ct-DNAwas found to form irregular structures, prob-
ably because the DNA samples utilized were sheared
(Fig. 3a). Figure 3b demonstrates that boric acid molecules
form large aggregates. The structural changes in ct-DNAwere
observed in the presence of two different molarities (1 and
5 mM) of boric acid. Conspicuous aggregates were observed
in the presence of 1 mM BA (Fig. 3c). Curiously, boric acid
molecules were homogenously dispersed and bore regular
shapes with diameters in the range of 10–15 nm. It is likely
that BA molecules bound to the exposed surfaces of double-
stranded DNA clusters, which indicates that boric acid could
bind to the ct-DNA. The resulting binding may be derived
from van der Waals and electrostatic interaction between ct-
DNA helix and boric acid. Ct-DNA could not be observed in
5 mM boric acid which indicated the excessive boric acid
made DNA denaturation.
Fourier Transform Infrared Analysis
Spectral analysis of the binding mode of BA to ct-DNAwas
investigated via FT-IR spectroscopy. In the region of 700–
Fig. 4 FT-IR spectra of ct-DNA–
BAmixtures in the region of 700–
1,800 cm−1. (a) Free
DNA(1 mM), (b) DNA+
0.25 mM BA, (c) DNA+0.5 mM
BA, and (d) DNA+1 mM BA
Fig. 5 ITC titration calorimetry curve of 5 mM BA binding to 0.5 mM
ct-DNA in double-distilled water (T=25 °C). Top panel shows the differ-
ential power of the experiment. Bottom panel shows integrated heat
change after each injection of BA
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1800 cm−1, several marker bands and shifts are tabulated in
Table 1. The peaks at 1715, 1663, 1604, and 1496 cm−1
correspond to the vibrations of guanine (G), thymine (T),
adenine (A), and cytosine (C), respectively [26]. When
1 mM BA is added to the DNA mixture, the cytosine band
at 1496 cm−1 shifts to 1499 cm−1. In addition, a number of
peaks around 1400–1500 cm−1 disappear upon the addition of
BA (Fig. 4). The spectral features for nitrogenous bases,
however, are overall similar to free DNA, which suggests that
BA does not intercalate between DNA strands. Peaks at 1231
and 1082 cm−1 are attributed to phosphate asymmetric and
symmetric stretching, and the band at 1231 cm−1 gradually
shifts to 1239 cm−1 for increasing concentrations of BA. This
phosphate asymmetry band is one of the markers for B-DNA
conformation, and its shift may be attributed to a distortion in
the conformation of DNA, which supports our CD spectros-
copy observations. The only change in the phosphate symme-
try peaks is a 1 cm−1 shift in the DNA–0.25 mMBA complex.
The sugar band at 1055 cm−1 shifts to 1049 or 1053 cm−1 in
the presence of high concentration of boric acid. Despite
minor shifts in those regions, our data suggests that the main
binding target of BA is deoxyribose, as evidenced by a major
shift from 891 to 881 cm−1 that appears in the deoxyribose
band following the addition of boric acid. Another B confor-
mation peak at 825 cm−1 slightly shifts to 822, 824, and
821 cm−1 in 0.25, 0.5, and 1 mM BA–DNA mixtures,
respectively.
Isothermal Titration Calorimetry
Isothermal titration calorimetry (ITC) is a powerful tool for
direct determination of thermodynamic parameters (ΔH,ΔG,
and ΔS) associated with binding reactions, stoichiometry of
interaction between two molecules (n), and binding affinity
(KA) [21]. Several reports in literature detail ITC-based quan-
titative measurements of interactions between biological mac-
romolecules, such as proteins [30–35] or DNA [36–39] and
metal ions. In this work, ITC was utilized to characterize the
thermodynamics of boric acid binding to ct-DNA. 5 mM BA
in double-distilled water was titrated into 0.5 mM ct-DNA; the
thermogram obtained is shown in Fig. 5. As it is known that
metal ions can competitively bind to Tris [40], double-distilled
water was utilized as solvent. Our results suggest that the
number of binding sites for the BA –ct-DNA complex forma-
tion is 0.2. Because the BA–ct-DNA interactions do not
involve the formation of a 1:1 bound complex, a sigmoidal
plot could not be fully fitted with the one-site binding model,
but a partial fit has been obtained. Furthermore, our ITC
results demonstrated that the rapid saturation of the BA–ct-
DNA complex resulted from the high initial molarity of BA.
Enthalpy change in calories per mole was found to be −920.6
(±1.44), which revealed the binding reaction is exothermic,
and the affinity constant Ka was found to be 9.54×10
4
(±1.51×104) (M−1). The reaction was enthalpically driven
with a slightly favorable contribution from an entropy change
(ΔS 5.97 cal/K.mol). Based on Eq. (1), the Gibb’s free energy
(ΔG) change was −28.416 kJmol−1.
Conclusions
In this report, we describe the binding properties of boric acid
to calf thymus DNA.
Hyperchromic shifts observed in UV–Vis results of ct-
DNA–boric acid complexes indicate that boric acid is capable
of DNA binding which is further supported by TEM obser-
vations. Our FT-IR data indicates that deoxyribose sugar of
DNA is the main target for binding of boric acid to ct-DNA.
Additionally, CD data indicated that although the secondary
structure of DNAwas not so much influenced after the treat-
ment with low concentrations of BA, DNA degradation
occurred at high concentrations. The study presented here
provided further evidence for a moderately strong interaction
between BA and ct-DNA.
Our investigation of the BA–DNA binding mechanism is
of considerable importance for the synthesis of novel boric
acid-based bioactive molecules and therapeutic agents for
cancer treatment. However, more sensitive methods like nu-
clear magnetic resonance (NMR) and X-ray photoelectron
spectroscopy (XPS) should be used to further investigate the
unique binding mode of boric acid to ct-DNA. While the
biochemical analysis of the association between BA and ct-
DNA is important to demonstrate the therapeutic potential of
boric acid, cellular uptake of boric acid in cancer cells is being
elucidated in our laboratory in order to identify the major
targets of boric acid.
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